Guo Wei-Xing, Man Xiao-Bo, Yuan Hai-Xin, Shi Jie, Xue Jie, Wu Meng-Chao, Cheng Shu-Qun
Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2094-7.
A comparative proteomic approach was used to analyze proteins relevant to portal vein tumor thrombus forming.
proteins extracted from five pairs of matched primary tumor/tumor thrombus samples in the same patient were separated by two-dimensional gel electrophoresis (2-DE). Selected proteins exhibiting statistically significant alternations were identified by mass spectrometry. Western blotting was further performed to examine the expression of the candidate proteins.
There were 20 significant proteins were identified in total, Among the 20 spots, 12 proteins were up-regulated proteins in primary tumor tissue, including Galectin-1, HMGBI, peroxiredoxin 1, Cyclophilin B, PCNA. whereas 8 were up-regulated proteins in tumor thrombus samples, including Annexin V, Triosephosphate Isomerase. Western blotting Confirmed the difference of Annexin V on protein level.
There are many proteins associated with the formation of PVTT in HCC. The overexpression of Annexin V may serve as a biomarker for early detection and therapeutic targets to HCC with PVTT.
采用比较蛋白质组学方法分析与门静脉肿瘤血栓形成相关的蛋白质。
从同一患者的五对匹配的原发性肿瘤/肿瘤血栓样本中提取蛋白质,通过二维凝胶电泳(2-DE)进行分离。对表现出统计学显著差异的选定蛋白质进行质谱鉴定。进一步进行蛋白质印迹法检测候选蛋白质的表达。
共鉴定出20种显著蛋白质。在这20个点中,12种蛋白质在原发性肿瘤组织中上调,包括半乳糖凝集素-1、高迁移率族蛋白B1、过氧化物还原酶1、亲环素B、增殖细胞核抗原。而8种在肿瘤血栓样本中上调,包括膜联蛋白V、磷酸丙糖异构酶。蛋白质印迹法证实了膜联蛋白V在蛋白质水平上的差异。
肝癌中存在许多与门静脉癌栓形成相关的蛋白质。膜联蛋白V的过表达可能作为肝癌伴门静脉癌栓早期检测的生物标志物和治疗靶点。